The year 2023 unfolded against a backdrop marred by the persistent emergence of substandard drugs, casting a shadow over India’s pharmaceutical landscape. However, amid these challenges, the Indian government stood as a bulwark of proactive measures, initiating a resolute campaign to fortify regulations and elevate drug standards, ensuring the nation’s pharmaceutical integrity.
The alarming issues…
